BAJAJHCARE vs PGHL: Stock Comparison

Bajaj Healthcare Limited vs Procter & Gamble Health Limited

Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings

Procter & Gamble Health Limited is the larger company by market capitalisation. Procter & Gamble Health Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Bajaj Healthcare Limited and Procter & Gamble Health Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BAJAJHCARE is more favourable on 1 of 13 scored metrics and PGHL on 12These counts are context-free and are not an overall rating.

Key Differences

Market Cap
PGHL is the larger company
₹11,208 Cr vs ₹1,087 Cr
P/E Ratio
PGHL has a lower P/E
34.28x vs 64.24x
P/B Ratio
BAJAJHCARE has a lower P/B
2.34x vs 21.36x
EPS
PGHL has higher earnings per share
₹196.64 vs ₹7
Dividend Yield
PGHL has a higher dividend yield
2.34% vs 0.26%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs -0.9%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 0%
Qtr Sales Growth
PGHL has stronger quarterly sales growth
19.1% vs -0.91%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAJAJHCAREPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBAJAJHCAREPGHL
Live Price₹323₹6,734
Day Change-12.55%-0.67%
Volume14.07 L4,697
52-Week High₹537.95₹6,975
52-Week Low₹272.35₹4,707
Distance from 52W High-39.96%-3.46%

Valuation

MetricBAJAJHCAREPGHL
Market Cap₹1,087 Cr₹11,208 Cr
P/E Ratio64.24x34.28x
P/B Ratio2.34x21.36x
EPS₹7₹196.64
Book Value₹167.01₹316.01
Dividend Yield0.26%2.34%

Growth

MetricBAJAJHCAREPGHL
Revenue Growth (TTM YoY)-0.9%19.1%
EPS Growth (TTM YoY)0%54.6%
Qtr Sales Growth-0.91%19.1%
Qtr Profit Growth19.2%54.6%

Profitability & Leverage

MetricBAJAJHCAREPGHL
ROE9.4%61.6%
ROCE11.5%83.5%
Net Margin2.56%23.22%
Operating Margin17.2%32.4%
Debt to Equity0.47x0.02x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAJAJHCAREPGHL
Promoter Holding58.59% 0.3 pp0%
FII Holding2.19% 0.21 pp6.33% 0.13 pp
DII Holding1.92% 0.99 pp12.44% 1.23 pp
Public Holding37.3% 0.48 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bajaj Healthcare Limited and Procter & Gamble Health Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.